{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:21:55Z","timestamp":1792819315877,"version":"4.5.0"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejmech.2020.112829","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T22:12:32Z","timestamp":1600207952000},"page":"112829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":661,"special_numbering":"C","title":["\u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8625-6351","authenticated-orcid":false,"given":"Lidia Moreira","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Nascimento Monteiro da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer J.","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112829_bib1","series-title":"Charbon et septic\u00e9mie","first-page":"101","author":"Pasteur","year":"1877"},{"issue":"3","key":"10.1016\/j.ejmech.2020.112829_bib2","article-title":"Louis Pasteur, the father of immunology","volume":"68","author":"Smith","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2020.112829_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0463.2009.02563.x","article-title":"Beta-lactam antibiotics: from antibiosis to resistance and bacteriology","volume":"118","author":"Kong","year":"2010","journal-title":"APMIS"},{"key":"10.1016\/j.ejmech.2020.112829_bib4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/jac\/5.3.249","article-title":"Pioneer work on the \u201cpenicillin phenomenon,\u201d 1870\u20131876","volume":"5","author":"Selwyn","year":"1979","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib5","first-page":"308","article-title":"Alexander Fleming and penicillin. The chance of a lifetime? N. C. Med","volume":"53","author":"Steffee","year":"1992","journal-title":"J."},{"key":"10.1016\/j.ejmech.2020.112829_bib6","first-page":"226","article-title":"On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.ejmech.2020.112829_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0025727300040758","article-title":"New light on the history of penicillin","volume":"26","author":"Hare","year":"1982","journal-title":"Med. His"},{"key":"10.1016\/j.ejmech.2020.112829_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0165-6147(79)90004-X","article-title":"The early years of the penicillin discovery","volume":"1","author":"Chain","year":"1979","journal-title":"Trends Pharmacol. Sci. J"},{"key":"10.1016\/j.ejmech.2020.112829_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/146837a0","article-title":"An enzyme from bacteria able to destroy penicillin","volume":"146","author":"Abraham","year":"1940","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib10","first-page":"3","article-title":"Further observations on penicillin 1941. Eur","volume":"42","author":"Abraham","year":"1992","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112829_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(00)41962-8","article-title":"General and local administration of penicillin","volume":"241","author":"Florey","year":"1943","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112829_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/br.38.3.291-335.1974","article-title":"Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes","volume":"38","author":"Blumberg","year":"1974","journal-title":"Bacteriol. Rev."},{"key":"10.1016\/j.ejmech.2020.112829_bib13","first-page":"9","article-title":"Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions","volume":"26","author":"Strominger","year":"1967","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ejmech.2020.112829_bib14","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/S0021-9258(18)93393-4","article-title":"Biosynthesis of the peptidoglycan of bacterial cell walls. 8. Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reaction in strains of Escherichia coli","volume":"243","author":"Izaki","year":"1968","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jb.117.2.926-927.1974","article-title":"D-alanine carboxypeptidase and cell wall cross-linking in Bacillus subtilis","volume":"117","author":"Sharpe","year":"1974","journal-title":"J.\u00a0Bacteriol."},{"key":"10.1016\/j.ejmech.2020.112829_bib16","author":"Heijenoort"},{"key":"10.1016\/j.ejmech.2020.112829_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1574-6976.2007.00097.x","article-title":"Evolution of peptidoglycan biosynthesis under the selective pressure of antibiotics in Gram-positive bacteria","volume":"32","author":"Mainardi","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112829_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro2677","article-title":"From the regulation of peptidoglycan synthesis to bacterial growth and morphology","volume":"10","author":"Typas","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib19","first-page":"47","article-title":"Of penicillium. New and future developments in microbial. Biotechnol","author":"Kumar","year":"2018","journal-title":"Bioeng"},{"key":"10.1016\/j.ejmech.2020.112829_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.mi.45.100191.000345","article-title":"Serine beta-lactamase and penicillin-binding proteins Annu","volume":"154","author":"Ghuysen","year":"1991","journal-title":"Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112262","article-title":"Breaking down the cell wall: strategies for antibiotic discovery targeting bacterial transpeptidases","volume":"194","author":"Cochrane","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2020.112829_bib22","article-title":"M.\u00a0Glycosyltransferases and transpeptidases\/penicillin-binding proteins: valuable targets for new antibacterials","volume":"12","author":"Sauvage","year":"2016","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2020.112829_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1574-6976.2006.00024.x","article-title":"Penicillin Binding Proteins: key players in bacterial cell cycle and drug resistance processes","volume":"30","author":"Macheboeuf","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112829_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.mib.2005.08.016","article-title":"\u03b2-Lactam antibiotic resistance: a current structural perspective","volume":"8","author":"Wilke","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib25","first-page":"285","article-title":"The active centres in penicillin-sensitive enzymes, Philos Trans. R. Soc. Lond","volume":"289","author":"Ghuysen","year":"1980","journal-title":"B\u00a0Biol. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib26","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/S0021-9258(19)85621-1","article-title":"The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase","volume":"255","author":"Yocum","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib27","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/S0021-9258(19)85620-X","article-title":"Sequence of active site peptides from the penicillin-sensitive D-alanine carboxypeptidase of Bacillus subtilis. Mechanism of penicillin action and sequence homology to beta-lactamases","volume":"255","author":"Waxman","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib28","first-page":"15","article-title":"Antibiotics (eds). Handbook of experimental pharmacology","author":"Demain","year":"1983","journal-title":"Berlim"},{"key":"10.1016\/j.ejmech.2020.112829_bib29","first-page":"1439","article-title":"Perspective: pharmacokinetics of Beta lactam antibiotics: clues from the past to help discover long acting oral drugs in the future. ACS Infect","volume":"4","author":"Smith","year":"2018","journal-title":"Dis"},{"key":"10.1016\/j.ejmech.2020.112829_bib30","series-title":"Medical Microbiology","article-title":"Structure","author":"Salton","year":"1996"},{"key":"10.1016\/j.ejmech.2020.112829_bib31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbamem.2015.11.004","article-title":"Gram-positive bacterial cell envelopes: the impact on the activity of antimicrobial peptides","volume":"1858","author":"Malanovic","year":"2016","journal-title":"BBA-Biomembranes"},{"key":"10.1016\/j.ejmech.2020.112829_bib32","series-title":"Fundamental Immunology","first-page":"1001","year":"2003"},{"key":"10.1016\/j.ejmech.2020.112829_bib33","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/318840","article-title":"Outer membrane channels and active transporters for the uptake of antibiotics","volume":"183","author":"Braun","year":"2001","journal-title":"J.\u00a0Infect. Diseases"},{"key":"10.1016\/j.ejmech.2020.112829_bib34","series-title":"\u03b2-Lactam Antibiotics. Encyclopedia of Microbiology","first-page":"274","author":"Liras","year":"2009"},{"key":"10.1016\/j.ejmech.2020.112829_bib35","first-page":"1203","article-title":"\u03b2-Lactam antibiotics","author":"Watkins","year":"2017","journal-title":"Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0032-9592(99)00052-7","article-title":"The combined effects of pH and temperature on penicillin G decomposition and its stability modeling","volume":"35","author":"Kheirolomoom","year":"1999","journal-title":"Process Biochem."},{"key":"10.1016\/j.ejmech.2020.112829_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/159747a0","article-title":"Stability of penicillin in aqueous solutions","volume":"159","author":"Halliwell","year":"1947","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib38","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/jps.2600651104","article-title":"Comparative stability of cephalosporins in aqueous solution: kinetics and mechanisms of degradation","volume":"65","author":"Yamana","year":"1976","journal-title":"J\u00a0Pharm Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib39","author":"Tsuji"},{"key":"10.1016\/j.ejmech.2020.112829_bib40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/BF00761593","article-title":"Stability of penicillins in aqueous solutions I. Oxacillin and phenoxymethylpenicillin","volume":"1","author":"Kondrat\u2019eva","year":"1967","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2020.112829_bib41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/B978-044452166-8\/50032-7","article-title":"Antibiotics","author":"Vardanyan","year":"2006","journal-title":"Synthesis of Essential Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib42","first-page":"182","article-title":"Phenoxymethylpenicillin or penicillin V; stability to gastric juices and biological activity","volume":"19","author":"Von Lorch","year":"1956","journal-title":"Rend. Ist. Super. Sanita"},{"key":"10.1016\/j.ejmech.2020.112829_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/9781119220787.ch22","article-title":"Benzathine penicillin, penicillin G, penicillin V, procaine penicillin (Penicillin)","author":"Schlossberg","year":"2017","journal-title":"Antibiotics Manual"},{"key":"10.1016\/j.ejmech.2020.112829_bib44","author":"Vardanyan"},{"key":"10.1016\/j.ejmech.2020.112829_bib45","author":"Farrington"},{"key":"10.1016\/j.ejmech.2020.112829_bib46","first-page":"78","article-title":"Penicillin G, penicillin V and other pharmaceutical improvements in the treatment of infections","volume":"12","author":"Farrar","year":"1990","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112829_bib47","first-page":"315","article-title":"Absorption and excretion of four penicillins. N. Engl","volume":"263","author":"McCarthy","year":"1960","journal-title":"J.\u00a0Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib48","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/1911091a0","article-title":"Some novel acid-stable penicillins","volume":"191","author":"Doyle","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1126\/science.99.2579.452","article-title":"Extraction of a highly potent penicillin inactivator from resistant staphylococci","volume":"99","author":"Kirby","year":"1944","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112829_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib51","first-page":"1899","article-title":"Pharmaceutical innovation: revolutionizing human health","volume":"43","author":"Landau","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.32607\/20758251-2010-2-3-47-61","article-title":"Protein engineering of penicillin acylase","volume":"2","author":"Tishkov","year":"2010","journal-title":"Acta Naturae"},{"key":"10.1016\/j.ejmech.2020.112829_bib53","first-page":"1734","article-title":"D.N do amaral. Homologation: a versatile molecular modification strategy to drug discovery. Curr. Top","volume":"19","author":"Lima","year":"2019","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jps.2600540135","article-title":"Stability of methicillin","volume":"54","author":"Schwartz","year":"1965","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/pgmj.40.Suppl.170","article-title":"A\u00a0survey of methicillin resistance in Staphylococcus aureus","volume":"40","author":"Parker","year":"1964","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1128\/AEM.02854-15","article-title":"Multidrug-resistant, methicillin-resistant Staphylococcus aureus clonal complex 97 lineage spreading in dairy cattle and pigs in Italy","volume":"82","author":"Feltrin","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib57","author":"Smith"},{"key":"10.1016\/j.ejmech.2020.112829_bib58","first-page":"64","article-title":"Mechanisms of resistance to beta-lactam antibiotics in","volume":"42","author":"Lacey","year":"1984","journal-title":"Staphylococcus aureus. Scand. J. Infect. Dis. Suppl"},{"key":"10.1016\/j.ejmech.2020.112829_bib59","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/jm00186a002","article-title":"A\u00a0multifaceted approach to the study of the side-chain conformation in beta-lactamase-resistant penicillins","volume":"23","author":"Blanpain","year":"1980","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1068-607X(98)00184-X","article-title":"The semisynthetic penicillins. Primary","volume":"6","author":"Oshiro","year":"1999","journal-title":"Care Update for OB\/GYNS"},{"key":"10.1016\/j.ejmech.2020.112829_bib61","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cpt196232224","article-title":"Clinical pharmacology of the semisynthetic penicillins","volume":"3","author":"Dineen","year":"1962","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112829_bib62","series-title":"The Pharmacological Basis of Therapeutics","first-page":"891","author":"Brunton","year":"2011"},{"key":"10.1016\/j.ejmech.2020.112829_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1068-607X(97)00012-7","article-title":"Penicillin and ampicillin","volume":"4","author":"Raynor","year":"1997","journal-title":"Prim. Care Update OB\/GYNS"},{"key":"10.1016\/j.ejmech.2020.112829_bib64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.2042-7158.1974.tb09302.x","article-title":"Spectrophotometric determination of ampicillin sodium in the presence of its degradation and polymerization products","volume":"26","author":"Bundgaard","year":"1974","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.ejmech.2020.112829_bib65","first-page":"ME01","article-title":"Ampicillin: rise fall and resurgence","volume":"8","author":"Kaushik","year":"2014","journal-title":"J.\u00a0Clin. Diagn. Res."},{"key":"10.1016\/j.ejmech.2020.112829_bib66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF01975036","article-title":"Antibiotic uptake into gram-negative bacteria","volume":"7","author":"Hancock","year":"1988","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib67","first-page":"357","article-title":"A\u00a0discussion on penicillin and related antibiotics-past, present and future","volume":"179","author":"Nayler","year":"1971","journal-title":"Biol. Sci."},{"issue":"5817","key":"10.1016\/j.ejmech.2020.112829_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.3.5817.13","article-title":"Amoxycillin: a new semi-synthetic penicillin","volume":"3","author":"Sutherland","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejmech.2020.112829_bib69","first-page":"291","article-title":"Lalit singh, suruchi singh, comparative study between penicillin and ampicillin","volume":"1","author":"Sharma","year":"2013","journal-title":"Scholars J. Appl. Med. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib70","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/122.Supplement_1.S1","article-title":"Carbenicillin: chemistry and mode of action","volume":"122","author":"Butler","year":"1970","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/0929867053363540","article-title":"Bioisosterism: a useful strategy for molecular modification and drug design","volume":"12","author":"Lima","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib72","first-page":"61","article-title":"Carbenicillin and ticarcillin","volume":"66","author":"Neu","year":"1982","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejmech.2020.112829_bib73","series-title":"Antibiotic Discovery and Development Springer Science","first-page":"79","year":"2011"},{"key":"10.1016\/j.ejmech.2020.112829_bib74","first-page":"26","article-title":"Bisodic alpha-carboxy benzyl-penicillin (carbenicillin): antimicrobial activity on strains of Pseudomonas aeruginosa. Ann. Ist. Super","volume":"10","author":"Notarrigo","year":"1974","journal-title":"Sanitarian"},{"key":"10.1016\/j.ejmech.2020.112829_bib75","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/AAC.37.11.2327","article-title":"Stereoselective renal tubular secretion of carbenicillin","volume":"37","author":"Itoh","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib76","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/AAC.13.6.930","article-title":"Azlocillin and mezlocillin: new ureido penicillins","volume":"13","author":"Fu","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib77","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1185\/03007998309109801","article-title":"Comparative in\u00a0vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin","volume":"8","author":"Chattopadhyay","year":"1983","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2020.112829_bib78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/clinids\/6.1.13","article-title":"The acylampicillins: mezlocillin, piperacillin, and azlocillin","volume":"6","author":"Drusano","year":"1984","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib79","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-97-5-755","article-title":"mezlocillin, and piperacillin: new broad-spectrum penicillins","volume":"97","author":"Eliopoulos","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib80","author":"Sepp\u00e4l\u00e4"},{"key":"10.1016\/j.ejmech.2020.112829_bib81","first-page":"12","article-title":"Hypersensitivity reactions to \u03b2-lactams: relevance of hapten-protein conjugates","volume":"25","author":"Ariza","year":"2015","journal-title":"J\u00a0Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.ejmech.2020.112829_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/206362a0","article-title":"Penicillin allergy: the Formation of the penicilloyl determinant","volume":"206","author":"Batchelor","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib83","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.1998.00122.x","article-title":"Molecular features of penicillin allergy","volume":"110","author":"Weltzien","year":"1998","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2020.112829_bib84","first-page":"1684","article-title":"Degradation of \u03b2-lactam antibiotics","volume":"87","author":"Deshpande","year":"2004","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.1998.00122.x","article-title":"Molecular features of penicillin allergy","volume":"110","author":"Weltzien","year":"1998","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2020.112829_bib86","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.anai.2018.09.459","article-title":"Penicillin minor determinants: history and relevance for current diagnosis","volume":"121","author":"Adkinson","year":"2018","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejmech.2020.112829_bib87","first-page":"28","article-title":"Penicillin G\u2019s function, metabolites, allergy, and resistance","volume":"1","author":"Canzani","year":"2017","journal-title":"J.\u00a0Nutr. Hum. Health"},{"key":"10.1016\/j.ejmech.2020.112829_bib88","first-page":"1","article-title":"The complexity of T cell\u2013mediated penicillin hypersensitivity reactions","author":"Goh","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.ejmech.2020.112829_bib89","article-title":"Cephalosporin C, a new antibiotic containing sulphur and D-\u03b1-aminoadipic acid","volume":"548","author":"Newton","year":"1955","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib90","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/clinids\/1.1.99","article-title":"A\u00a0glimpse of the early history of the cephalosporins","volume":"1","author":"Abraham","year":"1979","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib91","series-title":"Cephalosporins and Penicillins: Chemistry and Biology","first-page":"p.768","author":"Flynn","year":"2013"},{"key":"10.1016\/j.ejmech.2020.112829_bib92","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/29575","article-title":"Structure of a cephalosporin synthase","volume":"394","author":"Valeg\u00e5rd","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0732-8893(89)90042-4","article-title":"A\u00a0review of cephalosporin metabolism: a lesson to be learned for future chemotherapy. Diagn","volume":"12","author":"Jones","year":"1989","journal-title":"Microbiol. Infect. Dis"},{"key":"10.1016\/j.ejmech.2020.112829_bib94","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-008044992-0.00202-9","article-title":"Cephalosporins","volume":"2","author":"Alcaide","year":"2008","journal-title":"Comprehensive Heterocyclic Chemistry III"},{"key":"10.1016\/j.ejmech.2020.112829_bib95","first-page":"376","article-title":"Advances in the field of producing semisynthetic cephalosporins","volume":"24","author":"Povarov","year":"1979","journal-title":"Antibiotiki"},{"key":"10.1016\/j.ejmech.2020.112829_bib96","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.7164\/antibiotics.33.1177","article-title":"Semisynthetic. BETA.-lactam antibiotics III. Cephalosporin derivatives in the furyl series. Chemical and microbiological properties. J","volume":"33","author":"Tinti","year":"1980","journal-title":"Antibiot"},{"key":"10.1016\/j.ejmech.2020.112829_bib97","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.7164\/antibiotics.32.1311","article-title":"Semisynthetic, BETA.-lactam antibiotics. II. Cephalosporin derivatives in the naphthalene series Chemical and microbiological properties. J","volume":"32","author":"Quaresima","year":"1979","journal-title":"Antibiot"},{"key":"10.1016\/j.ejmech.2020.112829_bib98","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.7164\/antibiotics.39.1236","article-title":"Semisynthetic.BETA.-lactam antibiotics. II Synthesis and antibacterial activity of 7-BETA.-(2-(acylamino)-2-(2-aminothiazol-4-yl)acetamido)cephalosporins. J","volume":"39","author":"Arimoto","year":"1986","journal-title":"Antibiot"},{"key":"10.1016\/j.ejmech.2020.112829_bib99","first-page":"956","article-title":"Semisynthetic beta-lactam antibiotics. VI. Synthesis and antimicrobial activity of alpha-hydrazonobenzylcephalosporins","volume":"40","author":"Monguzzi","year":"1985","journal-title":"Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2165\/00003495-199345050-00008","article-title":"Loracarbef: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy","volume":"45","author":"Brogden","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib101","first-page":"321","volume":"27","author":"Force","year":"1993","journal-title":"Loracarbef: A New Orally Administered Carbacephem Antibiotic. Ann. Pharmacot"},{"key":"10.1016\/j.ejmech.2020.112829_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/AAC.12.2.157","article-title":"Comparative pharmacology of cefaclor and cephalexin. Antimicrob","volume":"12","author":"Korzeniowski","year":"1977","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112829_bib103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199345020-00008","article-title":"Cefprozil: a review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential","volume":"45","author":"Wiseman","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib104","first-page":"188","article-title":"Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime","volume":"19","author":"Tartaglione","year":"1985","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.ejmech.2020.112829_bib105","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1093\/infdis\/137.Supplement.S10","article-title":"Cefamandole: a review of chemistry and microbiology","volume":"137","author":"Kaiser","year":"1978","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib106","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003495-197917040-00001","volume":"17","author":"Brogden","year":"1979","journal-title":"Cefuroxime. Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib107","article-title":"The association between cephalosporin and hypoprothrombinemia: a systematic review and meta-analysis. Int. J. Environ. Res. Public health","volume":"3937","author":"Park","year":"2019","journal-title":"16"},{"key":"10.1016\/j.ejmech.2020.112829_bib108","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/bmj.290.6472.878","article-title":"Third generation cephalosporins","volume":"290","author":"Gould","year":"1985","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2020.112829_bib109","first-page":"705","article-title":"Third-generation cephalosporins","volume":"79","author":"Klein","year":"1995","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejmech.2020.112829_bib110","article-title":"Third-generation cephalosporins: a review","volume":"14","author":"Cunha","year":"1992","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112829_bib111","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0399-077X(05)80869-8","article-title":"Pharmacokinetic properties of new oral cephalosporins","volume":"22","author":"Kneer","year":"1992","journal-title":"Med. Maladies Infect."},{"key":"10.1016\/j.ejmech.2020.112829_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/10.suppl_C.1","article-title":"Ceftizoxime and other third-generation cephalosporins: structure-activity relationships","volume":"10","author":"Dunn","year":"1982","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib113","first-page":"314","article-title":"Hypoprothrombinemia associated with cefoperazone treatment","volume":"18","author":"Cristiano","year":"1984","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.ejmech.2020.112829_bib114","first-page":"283","article-title":"Third generation cephalosporins","volume":"66","author":"Cunha","year":"1982","journal-title":"Med. Clin."},{"key":"10.1016\/j.ejmech.2020.112829_bib115","first-page":"463","article-title":"Cefepime: a new fourth-generation cephalosporin","volume":"51","author":"Okamoto","year":"1994","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.ejmech.2020.112829_bib116","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1469-0691.1997.tb00649.x","article-title":"Fourth-generation cephalosporins: a review of in\u00a0vitro activity, pharmacokinetics, pharmacodynamics and clinical utility","volume":"3","author":"Garau","year":"1997","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2020.112829_bib117","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003495-199447030-00007","article-title":"Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"47","author":"Barradell","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","article-title":"Efficacy and safety of cefepime: a systematic review and meta-analysis","volume":"7","author":"Yahav","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112829_bib119","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejmech.2020.112829_bib120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2165\/00003495-200969070-00003","article-title":"Ceftaroline: a novel broad-spectrum cephalosporin with activity against meticillin-resistant Staphylococcus aureus","volume":"69","author":"Zhanel","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40121-013-0010-x","article-title":"Ceftaroline fosamil: a brief clinical review","volume":"2","author":"Shirley","year":"2013","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ejmech.2020.112829_bib122","first-page":"1","article-title":"Efficacy and safety of ceftaroline: systematic review and meta-analysis. Therapeutic advances in infectious disease","author":"Rosanova","year":"2018","journal-title":"Ther. Adv. Infect. Dis"},{"key":"10.1016\/j.ejmech.2020.112829_bib123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijantimicag.2019.08.012","article-title":"Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults","volume":"54","author":"Welte","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112829_bib124","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003088-200847010-00003","article-title":"Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity","volume":"47","author":"Murthy","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2020.112829_bib125","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/AAC.48.7.2570-2575.2004","article-title":"Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers","volume":"48","author":"Schmitt-Hoffmann","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib126","first-page":"1","article-title":"Ceftobiprole: drug evaluation and place in therapy","author":"Giacobbe","year":"2019","journal-title":"Expert Rev Anti-Infe"},{"issue":"7","key":"10.1016\/j.ejmech.2020.112829_bib127","article-title":"Cephalosporins: a focus on side chains and \u03b2-lactam cross-reactivity","volume":"103","author":"Chaudhry","year":"2019","journal-title":"Pharmacy"},{"key":"10.1016\/j.ejmech.2020.112829_bib128","first-page":"804","article-title":"Cephalosporin allergy. N. Engl","volume":"345","author":"Kelkar","year":"2001","journal-title":"J.\u00a0Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1331\/JAPhA.2008.07006","article-title":"Cephalosporin use in treatment of patients with penicillin allergies","volume":"48","author":"DePestel","year":"2008","journal-title":"J.\u00a0Am. Pharm. Assoc."},{"key":"10.1016\/j.ejmech.2020.112829_bib130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","article-title":"The use of cephalosporins in penicillin-allergic patients: a literature review","volume":"42","author":"Campagna","year":"2012","journal-title":"J.\u00a0Emerg. Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaci.2005.10.032","article-title":"Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins","volume":"117","author":"Antunez","year":"2006","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2020.112829_bib132","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/imj.14229","article-title":"Immediate cephalosporin allergy","volume":"49","author":"Yuson","year":"2019","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ejmech.2020.112829_bib133","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/289590a0","article-title":"Sulfazecin and isosulfazecin, novel beta-lactam antibiotics of bacterial origin","volume":"289","author":"Imada","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib134","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/291489a0","article-title":"Monocyclic beta-lactam antibiotics produced by bacteria","volume":"291","author":"Sykes","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112829_bib135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/AAC.21.1.85","article-title":"Aztreonam (sq 26, 776), a synthetic monobactam specifically active against aerobic gram-negative bacteria","volume":"21","author":"Sykes","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib136","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7164\/antibiotics.34.621","article-title":"Kishi, Sulfazecin, a novel beta-lactam antibiotic of bacterial origin. Isolation and chemical characterization","volume":"34","author":"Asai","year":"1981","journal-title":"J.\u00a0Antibiot"},{"key":"10.1016\/j.ejmech.2020.112829_bib137","series-title":"Meyler\u2019s Side Effects of Drugs: Monobactams","first-page":"1097","author":"Paul","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112829_bib138","series-title":"Chirality in Antibacterial Agents. Comprehensive Chirality","first-page":"30","author":"Paris","year":"2012"},{"key":"10.1016\/j.ejmech.2020.112829_bib139","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1021\/jm060096t","article-title":"Assessing the protonation state of drug molecules: the case of aztreonam","volume":"49","author":"D\u00edaz","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib140","first-page":"22002","article-title":"Structural basis for effectiveness of siderophore-conjugated monocarbams against clinically relevant strains of","author":"Han","year":"2010","journal-title":"Pseudomonas aeruginosa"},{"key":"10.1016\/j.ejmech.2020.112829_bib141","first-page":"46","volume":"302","author":"Westley-Horton","year":"1991","journal-title":"Aztreonam: A Review of the First Monobactam. Am. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib142","series-title":"Antimicrobial Chemotherapy. Biofilms in Infection: Prevention and Control","first-page":"209","author":"Kuriyama","year":"2014"},{"key":"10.1016\/j.ejmech.2020.112829_bib143","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/jac\/dkw231","article-title":"A\u00a0review of the pharmacokinetics and pharmacodynamics of aztreonam","volume":"71","author":"Ramsey","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib144","first-page":"4239","article-title":"In\u00a0vitro activity of aztreonam-avibactam against a global collection of gram-negative pathogens from 2012 and 2013","volume":"59","author":"Biedenbach","year":"2015","journal-title":"Ant. Agents Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/08998280.2001.11927741","article-title":"Cross-reactivity of beta-lactam antibiotics","volume":"14","author":"James","year":"2001","journal-title":"Baylor Univ. Med. Cent. Proc"},{"key":"10.1016\/j.ejmech.2020.112829_bib146","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2014.10.011","article-title":"Tolerability of aztreonam and carbapenems in patients with IgE-mediated hypersensitivity to penicillins","volume":"135","author":"Gaeta","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2020.112829_bib147","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: past, present and future. Ant","volume":"55","author":"Papp-Wallace","year":"2011","journal-title":"Agents Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib148","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000070616","article-title":"The art of fusion: from penams and cephems to penems","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejmech.2020.112829_bib149","series-title":"The 16th Interscience Conference on Antimicrobial Agents and Chemotherapy","first-page":"228","author":"Kropp","year":"1976"},{"key":"10.1016\/j.ejmech.2020.112829_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/12.suppl_D.1","article-title":"Thienamycin: development of imipenem-cilastatin","volume":"12","author":"Kahan","year":"1983","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib151","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.apsb.2019.02.005","article-title":"Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)","volume":"9","author":"Huo","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2020.112829_bib152","author":"Hubschwerlen"},{"key":"10.1016\/j.ejmech.2020.112829_bib153","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0924-8579(96)00347-0","article-title":"Meropenem: evolution of a new generation carbapenem","volume":"8","author":"Blumer","year":"1997","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2020.112829_bib154","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/00003495-200059030-00016","article-title":"Meropenem: a review of its use in patients in intensive care","volume":"59","author":"Hurst","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00003495-199550010-00007","volume":"50","author":"Wiseman","year":"1995","journal-title":"Meropenem. Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib156","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.22.1.62","article-title":"Metabolism of thienamycin and related carbapenems antibiotics by the renal dipeptidase, dehydropeptidase-I","volume":"22","author":"Kropp","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib157","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/AAC.43.8.2010","article-title":"In\u00a0vitro antibacterial activity of LIC11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity","volume":"43","author":"Hikida","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib158","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/14787210.2018.1496821","article-title":"Tebipenem, the first oral carbapenem antibiotic","volume":"16","author":"Jain","year":"2018","journal-title":"Expert Rev. Anti-infect. Ther."},{"key":"10.1016\/j.ejmech.2020.112829_bib159","doi-asserted-by":"crossref","first-page":"e00603","DOI":"10.1128\/AAC.00603-19","article-title":"Pharmacodynamics of tebipenem: new options for oral treatment of multidrug-resistant gram-negative infections","volume":"63","author":"McEntee","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/DDDT.S3083","article-title":"Characteristics of doripenem: a new broad-spectrum antibiotic","volume":"3","author":"Alvarez-Lerma","year":"2009","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2020.112829_bib161","first-page":"789","article-title":"Doripenem: a new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities. Ther. Clin","volume":"3","author":"Walsh","year":"2007","journal-title":"Risk Manag."},{"key":"10.1016\/j.ejmech.2020.112829_bib162","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2165\/00003495-200363170-00006","article-title":"Ertapenem: a review of its use in the management of bacterial infections","volume":"63","author":"Curran","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib163","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14787210.3.1.23","article-title":"Ertapenem: review of a new carbapenem","volume":"3","author":"Zhanel","year":"2005","journal-title":"Expert. Rev. Anti-Infe"},{"key":"10.1016\/j.ejmech.2020.112829_bib164","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2165\/00003495-200262150-00005","volume":"62","author":"Perry","year":"2002","journal-title":"Biapenem. Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib165","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1128\/AAC.38.4.889","article-title":"In\u00a0vitro activity of biapenem (L-627), a new carbapenem, against anaerobes","volume":"38","author":"Aldridge","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib166","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/AAC.42.6.1433","article-title":"Pharmacokinetics and safety of a new parenteral carbapenem antibiotic, biapenem (L-627)","volume":"42","author":"Kozawa","year":"1998","journal-title":"Elderly Subjects. Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112829_bib167","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/157341211797457989","article-title":"A.\u00a0Recent advances in stability studies of carbapenems","volume":"7","author":"Cielecka-Piontek","year":"2011","journal-title":"Curr. Pharmaceut. Anal."},{"key":"10.1016\/j.ejmech.2020.112829_bib168","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7164\/antibiotics.48.408","article-title":"Structural features resulting in convulsive activity of carbapenem compounds; effect of C2 side chain J","volume":"48","author":"Sunagawa","year":"1995","journal-title":"Antibiot"},{"key":"10.1016\/j.ejmech.2020.112829_bib169","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(00)00128-4","article-title":"Carbapenemases: a problem in waiting?","volume":"3","author":"Livermore","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib170","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.41.2.223","article-title":"Carbapenem-hydrolysing beta-lactamases","volume":"41","author":"Rasmussen","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib171","article-title":"Carbapenem resistance: a review. Med. Sci","volume":"1","author":"Codjoe","year":"2017","journal-title":"6"},{"key":"10.1016\/j.ejmech.2020.112829_bib172","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0098","article-title":"A\u00a0review on bacterial resistance to carbapenems: epidemiology, detection and treatment options","volume":"6","author":"Elshamy","year":"2020","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.ejmech.2020.112829_bib173","series-title":"Recent Advances in the Chemistry of Beta-Lactams","first-page":"167","author":"Woodward","year":"1977"},{"issue":"10","key":"10.1016\/j.ejmech.2020.112829_bib174","article-title":"Recent advances in the chemistry of \u03b2-lactam antibiotics: second international symposium","volume":"44","author":"Sammes","year":"1982","journal-title":"Biochem. Educ."},{"key":"10.1016\/j.ejmech.2020.112829_bib175","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1592\/phco.23.14.1497.31937","article-title":"Chemical and microbiologic aspects of penems, a distinct class of \u03b2-lactams: focus on faropenem","volume":"23","author":"Miller","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2020.112829_bib176","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/39.1.35","article-title":"The in\u00a0vitro activity of faropenem, a novel oral penem","volume":"39","author":"Woodcock","year":"1997","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib177","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1586\/14787210.5.2.185","article-title":"Faropenem: review of a new oral penem","volume":"5","author":"Schurek","year":"2007","journal-title":"Expert. Ver. Anti-Infe"},{"key":"10.1016\/j.ejmech.2020.112829_bib178","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1358\/dof.2002.027.03.659134","article-title":"Faropenem daloxate","volume":"27","author":"Sorbera","year":"2002","journal-title":"Drugs Future"},{"key":"10.1016\/j.ejmech.2020.112829_bib179","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jac\/39.3.415","article-title":"Pharmacodynamic properties of faropenem demonstrated by studies of time- kill kinetics and postantibiotic effect","volume":"39","author":"Boswell","year":"1997","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib180","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1128\/AAC.33.8.1160","article-title":"In\u00a0vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents","volume":"33","author":"Gootz","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib181","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/AAC.01557-08","article-title":"Antianaerobic activity of sulopenem compared to six other agents. Antimicrob","volume":"53","author":"Ednie","year":"2009","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112829_bib182","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01832-18","article-title":"In\u00a0vitro activity of sulopenem, an oral penem, against urinary isolates of Escherichia coli","volume":"63","author":"Karlowsky","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib183","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.35.4.665","article-title":"Pharmacokinetics of the penem CP-65,207 and its separate stereoisomers in humans","volume":"35","author":"Foulds","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib184","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/IM9.0000000000000015","article-title":"Faropenem susceptibility of multidrug-resistant contemporary clinical isolates from zhejiang province, China","volume":"2","author":"Feng","year":"2020","journal-title":"Infectious Microbes & Diseases"},{"key":"10.1016\/j.ejmech.2020.112829_bib185","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejmech.2017.03.022","article-title":"Recent updates of carbapenem antibiotics","volume":"131","author":"El- Gamal","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib186","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072446","article-title":"Beta-lactamase stability of faropenem","volume":"49","author":"Dalhoff","year":"2003","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejmech.2020.112829_bib187","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1128\/AAC.46.9.2901-2907.2002","article-title":"Method for estimation of low outer membrane permeability to beta-lactam antibiotics","volume":"46","author":"Lakaye","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib188","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1369-5274(98)80083-0","article-title":"Multiple antibiotic resistance and efflux","volume":"1","author":"Nikaido","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib189","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/cr030102i","article-title":"Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity","volume":"105","author":"Fisher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112829_bib190","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1074-5521(96)90182-9","article-title":"Molecular evolution of bacterial b-lactam resistance","volume":"3","author":"Knox","year":"1996","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112829_bib191","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-7258(99)00027-3","article-title":"Class A beta-lactamase \u2013 enzyme-inhibitor interactions and resistance","volume":"83","author":"Yang","year":"1999","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2020.112829_bib192","article-title":"\u03b2-Lactam resistance mechanisms: gram-positive bacteria and Mycobacterium tuberculosis","volume":"6","author":"Fisher","year":"2016","journal-title":"CSH Perspect. Med"},{"key":"10.1016\/j.ejmech.2020.112829_bib193","series-title":"Pharmacology of Specific Drug Groups. Pharmacology and Therapeutics for Dentistry","first-page":"457","author":"Kumar","year":"2017"},{"key":"10.1016\/j.ejmech.2020.112829_bib194","first-page":"409","article-title":"Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum \u03b2-lactamases Res","volume":"155","author":"Shah","year":"2004","journal-title":"Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib195","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.mib.2005.08.016","article-title":"\u03b2-Lactam antibiotic resistance: a current structural perspective","volume":"8","author":"Wilke","year":"2005","journal-title":"Curr. Op. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib196","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nchembio.1950","article-title":"Class D \u03b2-lactamases do exist in Gram-positive bacteria","volume":"12","author":"Toth","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112829_bib197","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.33.3.259","article-title":"Characterization of beta-lactamases","volume":"33","author":"Bush","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib198","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib199","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00018-005-5148-6","article-title":"\u03b2-Lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome","volume":"62","author":"Fuda","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"issue":"146","key":"10.1016\/j.ejmech.2020.112829_bib200","article-title":"An enzyme from bact\u00e9ria able to destroy penicillin","volume":"837","author":"Abraham","year":"1940","journal-title":"Nature"},{"issue":"suppl.1","key":"10.1016\/j.ejmech.2020.112829_bib201","first-page":"S19","article-title":"Evolution and dissemination of \u03b2-lactamase accelerated by generations of \u03b2-lactam antibiotics Clin. Infect","volume":"24","author":"Medeiros","year":"1997","journal-title":"Dis"},{"key":"10.1016\/j.ejmech.2020.112829_bib202","first-page":"321","article-title":"The structure of beta-lactamases Phil. Trans. R. Soc. Lond","volume":"289","author":"Ambler","year":"1980","journal-title":"B.\u00a0Biol. Sci."},{"key":"10.1016\/j.ejmech.2020.112829_bib203","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.mib.2005.08.016","article-title":"\u03b2-Lactam antibiotic resistance: a current structural perspective","volume":"8","author":"Wilke","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib204","doi-asserted-by":"crossref","first-page":"12251","DOI":"10.1021\/bi961153v","article-title":"Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus","volume":"35","author":"Chen","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112829_bib205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A\u00a0functional classification scheme for \u03b2-lactamases and its correlation with molecular structure Antimicrob","volume":"40","author":"Bush","year":"1995","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112829_bib206","doi-asserted-by":"crossref","first-page":"12404","DOI":"10.1021\/bi980506i","article-title":"Crystal structure of the zinc-dependent beta-lactamase from Bacillus cereus at 1.9 \u00c5 resolution: binuclear active site with features of mononuclear enzyme","volume":"37","author":"Fabiane","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112829_bib207","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1074\/jbc.M512517200","article-title":"Catalytic mechanism od class B2 metallo-beta-lactamase","volume":"281","author":"Xu","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib208","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1078\/1438-4221-00198","article-title":"Molecular analysis of beta-lactamase structure and function","volume":"292","author":"Majiduddin","year":"2002","journal-title":"Int. J. Med. Microbiol"},{"key":"10.1016\/j.ejmech.2020.112829_bib209","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mib.2017.10.026","article-title":"Inhibitors of metallo-\u03b2-lactamases","volume":"39","author":"Rotondo","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib210","first-page":"1","article-title":"The mechanisms of catalysis by metallo -lactamases","author":"Page","year":"2008","journal-title":"Bioinorgan. Chem. Appl."},{"key":"10.1016\/j.ejmech.2020.112829_bib211","article-title":"R.A. Bonomo A.J. Vila, the reaction mechanism of metallo-\u0392-lactamases is tuned by the conformation of an active site mobile loop. Antimicrob","volume":"63","author":"Palacios","year":"2018","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112829_bib212","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","article-title":"\u03b2-Lactamases and \u03b2-lactamase inhibitors in the 21st century","volume":"431","author":"Tooke","year":"2019","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2020.112829_bib213","first-page":"591","article-title":"Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination","volume":"3","author":"Stein","year":"1984","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ejmech.2020.112829_bib214","first-page":"335","article-title":"Clavulanic acid: a review. Biotechnol","volume":"26","author":"Saudagar","year":"2008","journal-title":"Adv"},{"key":"10.1016\/j.ejmech.2020.112829_bib215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/jac\/dkg286","article-title":"A\u00a0review of the antimicrobial activity of clavulanate,","volume":"52","author":"Finlay","year":"2003","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib216","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(80)91118-6","article-title":"Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study","volume":"1","author":"Ball","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112829_bib217","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2165\/00003495-199039020-00008","article-title":"Amoxicillin\/clavulanate. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use","volume":"39","author":"Todd","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib218","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1179\/joc.1997.9.3.167","article-title":"Amoxycillin clavulanate: an assessment after 15 years of clinical application","volume":"9","author":"Ball","year":"1997","journal-title":"J.\u00a0Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib219","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112829_bib220","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/bi00604a025","article-title":"Chemical studies on the inactivation of Escherichia coli RTEM \u03b2-lactamase by clavulanic acid","volume":"17","author":"Charnas","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112829_bib221","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1021\/ja00064a003","article-title":"Inactivation of class A \u03b2-lactamases by clavulanic acid: the role of arginine-244 in a proposed nonconcerted sequence of events","volume":"115","author":"Imtiaz","year":"1993","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112829_bib222","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1021\/bi00513a004","article-title":"Inactivation of RTEM \u03b2-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme","volume":"20","author":"Fisher","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112829_bib223","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.cplett.2009.03.031","article-title":"Computational study on decarboxylation mechanism of \u03b2-lactamases inhibitors: clavulanate vs. sulbactam","volume":"472","author":"Li","year":"2009","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejmech.2020.112829_bib224","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1021\/bi00185a009","article-title":"Strucuture based analysis of the inhibition of the class A \u03b2-lactamases by sulbactam","volume":"33","author":"Imtiaz","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112829_bib225","first-page":"917","article-title":"Beta-lactamase DataBase (BLDB) \u2013 structure and function. J. Enzyme inhib","volume":"32","author":"Naas","year":"2017","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112829_bib226","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/13543784.9.2.247","article-title":"Beta-lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors","volume":"9","author":"Payne","year":"2005","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2020.112829_bib227","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00698-18","article-title":"Diversity and proliferation of metallo-\u03b2-lactamases: a clarion call for clinically effective metallo-\u03b2-lactamase inhibitors","volume":"84","author":"Somboro","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112829_bib228","doi-asserted-by":"crossref","first-page":"8755","DOI":"10.1002\/phar.1622","article-title":"The \u03b2-lactams strike back: ceftazidime-avibactam","volume":"35","author":"Zasowski","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmech.2020.112829_bib229","first-page":"20","article-title":"NXL-104, a novel beta-lactamase inhibitor with broad-spectrum activity","volume":"13","author":"Cattoir","year":"2011","journal-title":"J.\u00a0Anti-Infect"},{"key":"10.1016\/j.ejmech.2020.112829_bib230","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/AAC.00826-13","article-title":"New \u03b2-lactamase inhibitors: a therapeutic renaissance in an MDR world","volume":"58","author":"Drawz","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib231","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"PNAS USA"},{"key":"10.1016\/j.ejmech.2020.112829_bib232","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1128\/AAC.03057-14","article-title":"Avibactam and class C \u03b2-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance","volume":"58","author":"Lahiri","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112829_bib233","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bcp.2005.11.012","article-title":"Understanding the longevity of the \u03b2-lactam antibiotics and antibiotic\/\u03b2-lactamase inhibitor combination","volume":"71","author":"Buynak","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112829_bib234","doi-asserted-by":"crossref","first-page":"9639","DOI":"10.1002\/chem.202001261","article-title":"Elucidating the molecular basis of avibactam mediated inhibition of class A \u03b2-lactamases","volume":"26","author":"Das","year":"2020","journal-title":"Chem. Eur J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420308011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:21:20Z","timestamp":1759328480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420308011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":234,"alternative-id":["S0223523420308011"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112829","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-lactam antibiotics: An overview from a medicinal chemistry perspective","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112829"}}